A detailed history of Roble, Belko & Company, Inc transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 10,000 shares of STXS stock, worth $20,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$20,500
Previous $18,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

BUY
$1.51 - $2.27 $15,100 - $22,700
10,000 New
10,000 $15,000

Others Institutions Holding STXS

About Stereotaxis, Inc.


  • Ticker STXS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,790,096
  • Market Cap $153M
  • Description
  • Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...
More about STXS
Track This Portfolio

Track Roble, Belko & Company, Inc Portfolio

Follow Roble, Belko & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roble, Belko & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Roble, Belko & Company, Inc with notifications on news.